mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |